OpenVSafe by OpenVAERS
Search V-safe

8XY-29884-50104

3 vaccinations 11 coded responses 32 check-ins 11 free-text entries 0 call cases
Sex
Female
Age at first dose
41-45
ZIP prefix
631 / MO
Registered
2021-03-09
Relationship
Self
Race
Black or African American
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-03-09
    Registered in v-safe
  2. 2021-03-09
    Dose 1 — Pfizer-BioNTech
  3. 2021-03-10
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Site: Pain · None
    Adult check-in
  4. 2021-03-11
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Site: Pain · None
    Adult check-in
  5. 2021-03-12
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  6. 2021-03-13
    Survey response — days 1–6 daily, dose 1
    MedDRA: Mood swings — Feeling: Fair
    Free text: Mood swings
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  7. 2021-03-14
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  8. 2021-03-15
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Fatigue or tiredness
    Adult check-in
  9. 2021-03-16
    Survey response — day 7, dose 1
    MedDRA: Dizziness — Feeling: Good · Nausea
    Free text: Dizziness
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  10. 2021-03-30
    Dose 2 — Pfizer-BioNTech
  11. 2021-03-31
    Survey response — days 1–6 daily, dose 2
    MedDRA: Dizziness — Feeling: Fair · Muscle or body aches, Fatigue or tiredness
    Free text: Dizziness
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  12. 2021-04-01
    Survey response — days 1–6 daily, dose 2
    MedDRA: Fatigue — Feeling: Fair · Site: Pain, Swelling · Headache, Muscle or body aches · Be unable to work
    Free text: Exhaustion
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  13. 2021-04-02
    Health check-in — days 1–6 daily, dose 2
    Feeling: Poor · Site: Pain · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activities
    Adult check-in
  14. 2021-04-03
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Headache, Fatigue or tiredness
    Adult check-in
  15. 2021-04-04
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  16. 2021-04-05
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  17. 2021-04-06
    Health check-in — day 7, dose 2
    Feeling: Good · Diarrhea
    Adult check-in
  18. 2021-04-13
    Health check-in — day 14, dose 2
    Feeling: Good
    Adult check-in
  19. 2021-04-22
    Survey response — day 21, dose 2
    MedDRA: Condition aggravated, Depression, Pre-existing disease — Feeling: Good · Be unable to do your normal daily activities
    Free text: Depression has worsened over the last 3 weeks.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  20. 2021-04-27
    Health check-in — day 28, dose 2
    Feeling: Good
    Adult check-in
  21. 2021-05-06
    Health check-in — day 35, dose 2
    Feeling: Good
    Adult check-in
  22. 2021-05-11
    Health check-in — day 42, dose 2
    Feeling: Good
    Adult check-in
  23. 2021-06-30
    Survey response — 3 months, dose 2
    MedDRA: Abdominal pain upper, Dry eye — Feeling: Fair
    Free text: Sharp stomach cramping, and dry eyes.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  24. 2021-09-28
    Survey response — 6 months, dose 2
    MedDRA: Anxiety, Insomnia — Feeling: Good
    Free text: Sleeplessness and anxiety
    MedDRA releases: 2024-11 · check-in free text available
  25. 2021-12-13
    Dose 3 — Pfizer-BioNTech
  26. 2021-12-14
    Health check-in — days 1–6 daily, dose 3
    Feeling: Fair · Site: Pain, Swelling · Headache
    Adult check-in
  27. 2021-12-15
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · None
    Adult check-in
  28. 2021-12-16
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · None
    Adult check-in
  29. 2021-12-20
    Health check-in — day 7, dose 3
    Feeling: Good · None
    Adult check-in
  30. 2021-12-27
    Health check-in — day 14, dose 3
    Feeling: Good
    Adult check-in
  31. 2022-01-03
    Health check-in — day 21, dose 3
    Feeling: Good
    Adult check-in
  32. 2022-01-10
    Survey response — day 28, dose 3
    MedDRA: Exposure to SARS-CoV-2, Headache, Inner ear inflammation, Respiratory tract congestion — Feeling: Fair · Be unable to do your normal daily activities
    Free text: Congestion and headache Inflammation in the inner ear Member of household tested positive for COVID-19
    MedDRA releases: 2024-11 · check-in free text available
  33. 2022-01-19
    Survey response — day 35, dose 3
    MedDRA: Disturbance in attention, Fatigue, Somnolence — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities
    Free text: Exhaustion, it is difficult to maintain focus and even keep my eyes open several times a day.
    MedDRA releases: 2024-11 · check-in free text available
  34. 2022-01-26
    Health check-in — day 42, dose 3
    Feeling: Fair
    Adult check-in
  35. 2022-06-14
    Survey response — 6 months, dose 3
    MedDRA: Muscle spasms — Feeling: Fair
    Free text: Muscle spasms in my left arm.
    MedDRA releases: 2024-11 · check-in free text available
  36. 2022-12-16
    Survey response — 12 months, dose 3
    MedDRA: COVID-19, Concussion — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities
    Free text: Had concussion in Feb and COVID in April. It was horrendous.
    MedDRA releases: 2024-11 · check-in free text available

Vaccinations

DoseDateManufacturerCo-administered
12021-03-09Pfizer-BioNTech
22021-03-30Pfizer-BioNTech
32021-12-13Pfizer-BioNTech No

Free text

Release 5 — days 1–6 daily, dose 1

2021-03-13

Systemic reaction (other): Mood swings

Release 5 — day 7, dose 1

2021-03-16

Systemic reaction (other): Dizziness

Release 6 — days 1–6 daily, dose 2

2021-03-31

Systemic reaction (other): Dizziness

2021-04-01

Systemic reaction (other): Exhaustion

Release 7 — day 21, dose 2

2021-04-22

Symptoms: Depression has worsened over the last 3 weeks.

Release 9 — 3 months, dose 2

2021-06-30

Symptoms: Sharp stomach cramping, and dry eyes.

Release 9 — 6 months, dose 2

2021-09-28

Symptoms: Sleeplessness and anxiety

Release 10 — day 28, dose 3

2022-01-10

Symptoms: Congestion and headache Inflammation in the inner ear Member of household tested positive for COVID-19

Release 10 — day 35, dose 3

2022-01-19

Symptoms: Exhaustion, it is difficult to maintain focus and even keep my eyes open several times a day.

Release 12 — 6 months, dose 3

2022-06-14

Symptoms: Muscle spasms in my left arm.

Release 12 — 12 months, dose 3

2022-12-16

Symptoms: Had concussion in Feb and COVID in April. It was horrendous.

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDAbdominal pain upper ✓ ✓ ✓
SDAnxiety · · ✓
SDConcussion · · ✓
SDCondition aggravated ✓ ✓ ✓
SDCOVID-19 · · ✓
SDDepression ✓ ✓ ✓
SDDisturbance in attention · · ✓
SDDry eye ✓ ✓ ✓
SDExposure to SARS-CoV-2 · · ✓
SDFatigue · · ✓
SDHeadache · · ✓
SDInner ear inflammation · · ✓
SDInsomnia · · ✓
SDMuscle spasms · · ✓
SDPre-existing disease ✓ ✓ ✓
SDRespiratory tract congestion · · ✓
SDSomnolence · · ✓
SRODizziness ✓ ✓ ✓
SROFatigue ✓ ✓ ✓
SROMood swings ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release